The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
ROS-based dynamic therapy synergy with modulating tumor cell-microenvironment mediated by inorganic nanomedicine
Abstract
Abstract Dynamic therapy (DT) by in situ ROS generation is emerging as an attractive therapeutic modality with potential to treat deep-seated tumors, avoiding side effects to healthy tissues. As one kind of DT, photodynamic therapy (PDT) has been clinically approved for cancer treatment, but restricted to superficial lesions due to the poor tissue penetration depth of excitation lights. Therefore, there is an urgent need to find out some new strategies to produce ROS under external stimulation with high penetrability or even independent of external excitation. Inorganic nanomaterials-based nanomedicine, or inorganic nanomedicine which can be designed with unique physicochemical properties, can respond to external excitations such as near-infrared (NIR) light, ultrasound (US), X-ray, and microwave (MW), or trigger internal chemical/biological reaction in tumor region to produce ROS for DT, showing great advantages for deep-seated tumor treatment with high specificity, safety, and non-invasiveness. However, most of the DT strategies are highly relied on oxygen, while the tumor microenvironment (TME), especially tumor cell-microenvironment is characterized with hypoxia and high concentration of reductive glutathione (GSH), which will impede the generation and accumulation of ROS, thus severely restricting ROS induced oxidative injury. Therefore, it is crucial to improve the efficacy of DT to enhance the anti-tumor effect. In this review, we briefly summarize the latest advances in developing types of DT related to ROS generation, including NIR-induced photo-/pyroelectric dynamic therapy, US-triggered sono-/piezo-dynamic therapy, X-ray-stimulated radio-/radiodynamic therapy, MW-triggered microdynamic therapy, alternating current-triggered electrodynamic therapy, as well as some others manners independent of external excitation such as chemodynamic therapy and self-lightened PDT. More importantly, we summarize various strategies to modulate tumor cell-microenvironment to enhance the efficacy of DT, by reliving hypoxia, augmenting hydrogen peroxide (H2O2), adjusting the pH, and depleting GSH. In addition, we also discuss the significance of nanotoxicity assessments in safely designing inorganic nanomaterials-based nanomdicine, address the challenges and limitations of DT, and further put forward the development direction of DT for future clinical translation. We hope that this timely and comprehensive review would make the value and future prospects of inorganic nanomedicine to be seen, and more in-depth studies are needed to realize the conversion of inorganic nanomedicine mediated DT strategies in clinics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Intrinsic peroxidase-like activity of ferromagnetic nanoparticles
Gao, L., Zhuang, J., Nie, L., Zhang, J., Zhang, Y., Gu, N., Wang, T., Feng, J., Yang, D., Perrett, S., et al. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.260 · Cited by 7,483
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Multifunctional sonosensitizers in sonodynamic cancer therapy
Son, S., Kim, J. H., Wang, X., Zhang, C., Yoon, S. A., Shin, J., Sharma, A., Lee, M. H., Cheng, L., Wu, J., et al. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00648f · Cited by 1,150
Self-citationROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
Snezhkina, A. V., Kudryavtseva, A. V., Kardymon, O. L., Savvateeva, M. V., Melnikova, N. V., Krasnov, G. S., & Dmitriev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6175804 · Cited by 934
The Two Faces of Reactive Oxygen Species in Cancer
Reczek, C. R., & Chandel, N. S. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-041916-065808 · Cited by 602
Ultrasound‐Activated Sensitizers and Applications
Lin, X., Song, J., Chen, X., & Yang, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201906823 · Cited by 501
Kong, N., Tao, W., Ling, X., Wang, J., Xiao, Y., Shi, S., Ji, X., Shajii, A., Gan, S. T., Kim, N. Y., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1565 · Cited by 314
Cited by
Zhou, J., Xu, D., Tian, G., He, Q., Zhang, X., Liao, J., Mei, L., Chen, L., Gao, L., Zhao, L., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c13597 · Cited by 274
Nano-ROS-generating approaches to cancer dynamic therapy: Lessons from nanoparticles
Zhang, Q., Luo, Q., Liu, Z., Sun, M., & Dong, X. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.141225 · Cited by 94
Wang, G., Wu, W., Zhu, J.-J., & Peng, D. (2021) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2021.105781 · Cited by 61
Metadata
- Authors
- Zhong, X., Wang, X., Li, J., Hu, J., Cheng, L., & Yang, X.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 437
- Pages
- 213828
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W3134346117
- Cited by
- 159
- References
- 10
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ROS-based dynamic therapy synergy with modulating tumor cell-microenvironment mediated by inorganic nanomedicine. https://app.cochat.ai/papers/10.1016/j.ccr.2021.213828
- The paper
- Zhong, X., Wang, X., Li, J., Hu, J., Cheng, L., & Yang, X. (2021). ROS-based dynamic therapy synergy with modulating tumor cell-microenvironment mediated by inorganic nanomedicine. Coordination Chemistry Reviews. https://doi.org/10.1016/j.ccr.2021.213828
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.